Newsfeeds - Spark Newswire

4 minute read

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb’s Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings

Today, 2:41 PM

Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments served as catalysts during the week.

ACIU

4 minute read

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly

By Shanthi Rexaline

Today, 2:41 PM

Here's a roundup of top developments in the biotech space over the last 24 hours:

AGLE

18 minute read

Earnings Scheduled For November 10, 2021

By Benzinga Insights

Today, 2:41 PM

Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.

AACG

1 minute read

DiaMedica Therapeutics, Kintara Therapeutics Shares Move Higher; Trader Circulate TipRanks Article ‘2 “Strong Buy” Penny Stocks That Are Ready to Boom’

By Benzinga Newsdesk

Today, 2:41 PM

https://www.tipranks.com/news/article/2-strong-buy-penny-stocks-that-are-ready-to-boom

DMAC

7 minute read

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline

By Shanthi Rexaline

Today, 2:41 PM

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.

ADPT

1 minute read

DiaMedica Therapeutics Highlights Late-Breaking Data From Phase 2 REDUX Trial Of Its Chronic Kidney Disease Candidate At American Society Of Nephrology Kidney Meeting Nov. 4 At 1 p.m. EDT

By Benzinga Newsdesk

Today, 2:41 PM

DiaMedica Therapeutics Inc. (NASDAQ:DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that late-breaking data from

DMAC

1 minute read

DiaMedica Therapeutics Files For Offering Of Up To 7.65M Common Shares

By Benzinga Newsdesk

Today, 2:41 PM

-SEC Filing

DMAC

4 minute read

50 Biggest Movers From Yesterday

By Lisa Levin

Today, 2:41 PM

Gainers

AGMH

2 minute read

Mid-Day Market Update: Crude Oil Rises 2%; ASLAN Pharmaceuticals Shares Slide

By Lisa Levin

Today, 2:41 PM

Midway through trading Monday, the Dow traded up 0.70% to 35,041.74 while the NASDAQ fell 0.51% to 14,970.85. The S&P also rose, gaining 0.02% to 4,456.20.

APOP

3 minute read

31 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 2:41 PM

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares jumped 54.1% to $3.6998 after the company said its subsidiary, Skypersonic, Inc, won a five-year contract from NASA to provide drone and rover software, hardware, and support for the Simulated Mars mission.

APOP